Guardian Pharmacy Services
GRDN
51 hedge funds and large institutions have $142M invested in Guardian Pharmacy Services in 2024 Q3 according to their latest regulatory filings, with 51 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
105.31% more ownership
Funds ownership: 0% → 105.31% (+105%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
J. Goldman & Co
New York
|
+$12.7M |
| 2 |
ClearBridge Investments
New York
|
+$11.2M |
| 3 |
Woodline Partners
San Francisco,
California
|
+$9.6M |
| 4 |
Ophir Asset Management
Sydney,
Australia
|
+$9.43M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
+$8.96M |
Top Sellers
GRDN Hedge Fund Activity: Q3 2024 in Review
51 of the 6,987 institutional investors tracked by Wall St. Rank reported a position in Guardian Pharmacy Services (GRDN) for Q3 2024, worth a combined $142M.
Buyers outnumbered sellers: 51 funds opened new GRDN positions and 0 closed out — a net gain of 51 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was J. Goldman & Co, opening a new position worth an estimated $12.7M.
- 51 institutional investors held Guardian Pharmacy Services (GRDN) as of Q3 2024, up from 0 in Q2 2024.
- Funds reported $142M of Guardian Pharmacy Services stock for Q3 2024.
- 51 funds opened new Guardian Pharmacy Services positions in Q3 2024 and 0 closed out, a net change of +51 holders.
- The largest Guardian Pharmacy Services buyer in Q3 2024 was J. Goldman & Co, an estimated $12.7M added.
Based on aggregated 13F filings for Q3 2024.